1.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-005, NCT01100502
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C25001, 2010-024215-14, NCT01578499
|
|
3.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: C25002, 2011-001240-29, NCT01492088
|
|
4.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 12 to 75
Sponsor: NCI, Other
Protocol IDs: 2560.00, NCI-2012-00924, NCT01620229
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AAAJ5050, NCT01657331
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-0914, NCT01352520
|
|
7.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 11051, NCI-2011-01135, NCT01393717
|
|
8.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 6 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-012, NCT01421667
|
|
9.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 6 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-013, NCT01461538
|
|
10.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: NU 11H01, NCI-2011-00684, STU00046908, NCT01476410
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 to 72
Sponsor: Other
Protocol IDs: 11-142, NCT01508312
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-462, NCT01534078
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 60
Sponsor: Other
Protocol IDs: Targeted BEACOPP, NCT01569204
|
|
14.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2589.00, NCI-2012-00921, NCT01616680
|
|
15.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: LYMNHL0089, SU-06212011-7946, NCT01396070
|
|
16.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: LCCC 1115, NCT01578967
|
|
17.
|
Phase: No phase specified
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-17024, SGN 35-IST-006, NCT01671813
|
Mobile | Español
